Benzinga | Feb 8, 2021 12:26PM EST

Deutsche Bank Maintains Buy on Amedisys, Raises Price Target to $340

Deutsche Bank analyst Justin Bowers maintains Amedisys (NASDAQ:AMED) with a Buy and raises the price target from $275 to $340.